Search research articles
Contact Us
Filters
Showing results (81-90 of 226) with videos related to
Page
of 23
Sort By:
Pancreas
|
December 6, 2012
Role of endoscopic ultrasonography in evaluation of metastatic lesions to the pancreas: a tertiary cancer center experience
Muslim Atiq, Manoop S Bhutani, William A Ross, et al.
Biorxiv : the Preprint Server for Biology
|
April 20, 2026
A Counterfactual Framework for Directional Cell-Cell Interaction Analysis in Spatial Transcriptomics
Humaira Anzum, Veena Kochat, Suresh Satpati, et al.
Journal of Translational Medicine
|
November 8, 2018
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
Morten Lapin, Satu Oltedal, Kjersti Tjensvoll, et al.
JAMA Oncology
|
March 4, 2021
Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants: Findings From 2 Phase 2 Nonrandomized Clinical Trials
Milind Javle, Einat Shacham-Shmueli, Lianchun Xiao, et al.
Investigational New Drugs
|
May 7, 2013
The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancer
Mohamed A Khalil, Wei Qiao, Peter Carlson, et al.
BMC Cancer
|
April 21, 2026
Genomic landscape of cholangiocarcinoma in India: ethnic variants and implications for targeted therapy
Moushumi Suryavanshi, Vikas Ostwal, Milind Javle, et al.
Journal of Hematology & Oncology
|
May 31, 2018
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma
Reham Abdel-Wahab, Gauri R Varadhachary, Priya R Bhosale, et al.
Journal of Hepatology
|
March 30, 2026
Global patterns of mutational profiles in biliary tract cancer
Yan Zhu, Jason A Wu, Dengyong Zhang, et al.
The Oncologist
|
December 30, 2017
Portomesenteric Venous Stenting for Palliation of Ascites and Variceal Bleeding Caused by Prehepatic Portal Hypertension
Rahul A Sheth, Sharjeel H Sabir, Philip Parmet, et al.
Cancer
|
November 19, 2016
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study
Pat Gulhati, Kanwal Raghav, Rachna T Shroff, et al.
Page
of 23
Search research articles
Search
Showing results (81-90 of 226) with videos related to
Sort By:
Page
of 23
Pancreas
|
December 6, 2012
Role of endoscopic ultrasonography in evaluation of metastatic lesions to the pancreas: a tertiary cancer center experience
Muslim Atiq, Manoop S Bhutani, William A Ross, et al.
Biorxiv : the Preprint Server for Biology
|
April 20, 2026
A Counterfactual Framework for Directional Cell-Cell Interaction Analysis in Spatial Transcriptomics
Humaira Anzum, Veena Kochat, Suresh Satpati, et al.
Journal of Translational Medicine
|
November 8, 2018
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
Morten Lapin, Satu Oltedal, Kjersti Tjensvoll, et al.
JAMA Oncology
|
March 4, 2021
Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants: Findings From 2 Phase 2 Nonrandomized Clinical Trials
Milind Javle, Einat Shacham-Shmueli, Lianchun Xiao, et al.
Investigational New Drugs
|
May 7, 2013
The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancer
Mohamed A Khalil, Wei Qiao, Peter Carlson, et al.
BMC Cancer
|
April 21, 2026
Genomic landscape of cholangiocarcinoma in India: ethnic variants and implications for targeted therapy
Moushumi Suryavanshi, Vikas Ostwal, Milind Javle, et al.
Journal of Hematology & Oncology
|
May 31, 2018
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma
Reham Abdel-Wahab, Gauri R Varadhachary, Priya R Bhosale, et al.
Journal of Hepatology
|
March 30, 2026
Global patterns of mutational profiles in biliary tract cancer
Yan Zhu, Jason A Wu, Dengyong Zhang, et al.
The Oncologist
|
December 30, 2017
Portomesenteric Venous Stenting for Palliation of Ascites and Variceal Bleeding Caused by Prehepatic Portal Hypertension
Rahul A Sheth, Sharjeel H Sabir, Philip Parmet, et al.
Cancer
|
November 19, 2016
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study
Pat Gulhati, Kanwal Raghav, Rachna T Shroff, et al.
Page
of 23